Adjuvant capecitabine after neoadjuvant chemotherapy in breast cancer






Adjuvant Capecitabine for Breast Cancer after Preoperative

Jun 1 2017 Patients who have residual invasive carcinoma after the receipt of neoadjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)– ...


original reports - Adjuvant Capecitabine for Early Breast Cancer: 15

adjuvant capecitabine trials addressing breast cancer. The. 15-year analysis of OS was scheduled in after completion of chemotherapy whenever cancer was.
FULLTEXT


Adjuvant capecitabine-containing chemotherapy benefit and

Feb 5 2022 showed that adjuvant capecitabine following or added to ... chemotherapy for stage III HER2-negative breast cancer patients.
s y ?proof=tNature


CREATE-X a role for capecitabine in early-stage breast cancer: an

Breast cancer patients with residual disease after neoadjuvant chemotherapy and offering a course of adjuvant capecitabine or enrolling the patient in a ...
s ?proof=tConcernant





Effects of immune architecture on response to adjuvant capecitabine

benefit of adjuvant capecitabine par- ticularly in triple negative breast cancer (TNBC) patients with residual disease after neoadjuvant chemotherapy.


Real-world comparison of the impact of adjuvant capecitabine in

Efficacy and safety of neoadjuvant chemotherapy plus trastuzumab women with high-risk triple-negative breast cancer after neoadjuvant chemotherapy.



Triple-Negative Breast Cancer: A Review of Current Curative Intent

Jul 7 2022 breast cancer and without a pCR after neoadjuvant chemotherapy were ... of capecitabine usage in the neoadjuvant and adjuvant settings ...





The role of capecitabine-based neoadjuvant and adjuvant

Phase III trial of adjuvant Capecitabine after standard neo−/adjuvant chemotherapy in patients with early triple-negative breast Cancer (GEICAM/. 2003- 
s y


Adjuvant chemotherapy for breast cancer after preoperative

Jun 5 2020 breast cancer (BC) patients with no pathological complete response after neoadjuvant che- motherapy (NAC). The benefit of adjuvant ...


0